Study links increased dopamine synthesis to psychosis risk

01/18/2013 | News-Medical.Net

Researchers using 18F-DOPA-PET found that patients at an ultra-high risk (UHR) for psychosis show increased dopamine synthesis capacity in the whole striatum compared with mentally healthy subjects. "Clinical follow-up of our first cohort found that those UHR subjects with the highest levels of striatal 18F-DOPA uptake at presentation were the most likely to develop a psychotic disorder over the next three years," researchers said. The findings were published in Biological Psychiatry.

View Full Article in:

News-Medical.Net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD